Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Modern advances in long-acting peptide design, biased agonism, receptor de-orphanization, and systems pharmacology fundamentally alter the riskbenefit calculus of these targets
Gestational diabetes, a form that sometimes arises during pregnancy, normally resolves shortly after delivery
A phase 3 trial of simufilam (NCT05575076) was started in November 2022 to assess the long-term safety and tolerability of simufilam in participants with mild-to-moderate AD
Vegetables, fruits and whole grains are highly recommended
Dose adjustments, anti-nausea medications, or dietary counseling with a registered dietitian may be appropriate
It reduces hepatic inflammation and oxidative stress by modulating the SIRT1/Nrf2/NF-B axis, thereby restoring liver function
US$ 25.81
US$ 26.17
US$ 21.16
US$ 23.76
US$ 22.58
US$ 27.33
US$ 22.07
US$ 27.22
US$ 26.76
